Net Change In Cash - Corcept Therapeutics Inc (NASDAQ:CORT) - Alpha Spread

Corcept Therapeutics Inc
NASDAQ:CORT

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
NASDAQ:CORT
Watchlist
Price: 43.93 USD 1.5% Market Closed
Market Cap: 4.8B USD
Have any thoughts about
Corcept Therapeutics Inc?
Write Note

Corcept Therapeutics Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Corcept Therapeutics Inc
Net Change in Cash Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Corcept Therapeutics Inc
NASDAQ:CORT
Net Change in Cash
-$43.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Johnson & Johnson
NYSE:JNJ
Net Change in Cash
$3.7B
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Net Change in Cash
-$2.1B
CAGR 3-Years
38%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Net Change in Cash
-$1.6B
CAGR 3-Years
N/A
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Net Change in Cash
$5.7B
CAGR 3-Years
N/A
CAGR 5-Years
33%
CAGR 10-Years
N/A
Eli Lilly and Co
NYSE:LLY
Net Change in Cash
$529.1m
CAGR 3-Years
-15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Corcept Therapeutics Inc's Net Change in Cash?
Net Change in Cash
-43.7m USD

Based on the financial report for Jun 30, 2024, Corcept Therapeutics Inc's Net Change in Cash amounts to -43.7m USD.

What is Corcept Therapeutics Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
-1%

Back to Top